Showing results (1-10 of 19) with videos related to
Sort By:
Pageof 2
European Journal of Cancer (Oxford, England : 1990)|August 3, 2005
The finasteride prostate cancer prevention trial (PCPT)--what have we learned?J Kilian MellonSurgical Oncology|May 29, 2002
Contemporary cystectomy combined with ileal conduit or bladder substitutionAshok G Bhojwani, J Kilian MellonUrologia Internationalis|March 25, 2010
Management of the distal ureter during nephroureterectomy for upper urinary tract transitional cell carcinoma: a reviewEvangelos G Gkougkousis, J Kilian Mellon, T R Leyshon GriffithsUrologic Oncology|July 17, 2012
Defining prostate cancer risk before prostate biopsyRaj P Pal, Neil U Maitra, J Kilian Mellon, et al.Urologic Oncology|December 31, 2002
Resveratrol--a prostate cancer chemopreventive agent?Hari L Ratan, Will P Steward, Andreas J Gescher, et al.Molecular Biology of the Cell|September 15, 2007
Direct repression of cyclin D1 by SIP1 attenuates cell cycle progression in cells undergoing an epithelial mesenchymal transitionJakob Mejlvang, Marina Kriajevska, Cindy Vandewalle, et al.Molecular and Cellular Biology|October 4, 2005
Immediate and delayed effects of E-cadherin inhibition on gene regulation and cell motility in human epidermoid carcinoma cellsHenriette Andersen, Jakob Mejlvang, Shaukat Mahmood, et al.Current Cancer Drug Targets|August 28, 2012
Inhibition of STAT signalling in bladder cancer by diindolylmethane: relevance to cell adhesion, migration and proliferationYiyang Sun, Mai-Kim Cheng, Thomas R L Griffiths, et al.The Journal of Pathology|February 22, 2002
Expression of S100A4 protein is associated with metastasis and reduced survival in human bladder cancerBarry R Davies, Marie O'Donnell, Garrett C Durkan, et al.The American Journal of Pathology|February 13, 2002
Transfection of S100A4 produces metastatic variants of an orthotopic model of bladder cancerDiana Levett, Paul A Flecknell, Philip S Rudland, et al.Pageof 2